18.5 Conclusion
Combining metabolic, diffusion and haemodynamic information from 1H-MRSI, DWI and PWI with morphological information from conventional MRI undoubtedly improves the assessment of intracranial tumours, increasing the capability to discriminate between different tissues. Furthermore, using high-field MR can allow shorter imaging times for a given resolution, a higher resolution for a given imaging time, or combination of both, due to the higher SNR. Ashort acquisition time is preferable for the fast imaging of ill and sometimes poorly cooperative subjects, especially if long MR protocols are used. High spatial resolution allows high quality imaging and therefore additional diagnostic information. We suggest that the multiparametric MR approach, including 1H-MRSI, DWI and PWI in addition to conventional MRI, at 3 T may provide a non-invasive fast and accurate tool for the formulation of diagnosis and prognosis, the planning of treatment and the monitoring of therapeutic response in patients with brain tumours.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Behin A, Hoang-Xuan K, Carpentier AF, Delattre J-Y (2003) Primary brain tumours in adults. Lancet 361:323–331
Grant R (2004) Overview: brain tumour diagnosis and management. Royal College of Physicians guidelines. J Neurol Neurosurg Psychiatry 75(Suppl 2):18–23
Howe FA, Opstad KS (2003) 1H MR spectroscopy of brain tumor and masses. NMR Biomed 16:123–131
McKnight TR (2004) Proton magnetic resonance spectroscopic evaluation of brain tumor metabolism. Semin Oncol 31:605–617
Li X, Lu Y, Pirzkall A, McKnight T, Nelson SJ (2002) Analysis of the spatial characteristics of metabolic abnormalities in newly diagnosed glioma patients. J Magn Reson Imaging 16:229–237
Burtscher IM, Skagerberg G, Geijer B, et al. (2000) Proton MR spectroscopy and preoperative diagnostic accuracy: an evaluation of intracranial mass lesions characterized by stereotactic biopsy findings. Am J Neuroradiol 21:84–93
Dowling C, Bollen AW, Noworolski SM, et al. (2001) Preoperative proton MR spectroscopic imaging of brain tumors: correlation with histopathologic analysis of resection specimens. Am J Neuroradiol 22:604–612
Croteau D, Scarpace L, Hearshen D, et al. (2001) Correlation between magnetic resonance spectroscopy imaging and image-guided biopsies: semiquantitative and qualitative histopathological analyses of patients with untreated glioma. Neurosurgery 49:823–829
Rabinov JD, Lee PL, Barker FG, et al. (2002) In vivo 3-TMR spectroscopy in the distinction of recurrent glioma versus radiation effects: initial experience. Radiology 225:871–879
Tedeschi G, Lundbom N, Raman R, et al. (1997) Increased choline signal coinciding with malignant degeneration of cerebral gliomas: a serial proton magnetic resonance spectroscopy imaging study. J Neurosurg 87:516–524
Sener RN (2001) Diffusion MRI: apparent diffusion coefficient (ADC) values in the normal brain and a classification of brain disorders based on ADC values. Comput Med Imaging Graph 25:299–326
Kono K, Inoue Y, Nakayama K, et al. (2001) The role of diffusion-weighted imaging in patients with brain tumors. Am J Neuroradiol 22:1081–1088
Asao C, Korogi Y, Kitajima M, et al. (2005) Diffusion-weighted imaging of radiation-induced brain injury for differentiation from tumor recurrence. Am J Neuroradiol 26:1455–1460
Muti M, Aprile I, Principi M, et al. (2002) Study on the variations of the apparent diffusion coefficient in areas of solid tumor in high grade gliomas. Magn Reson Imaging 20:635–641
Yamasaki F, Kurisu K, Satoh K, et al. (2005)Apparent diffusion coefficient of human brain tumors at MR imaging. Radiology 235:985–991
Lam WWM, Poon WS, Metreweli C (2002) Diffusion MR imaging in glioma: does it have any role in the pre-operation determination of grading of glioma? Clin Radiol 57:219–225
Tien RD, Felsberg GJ, Friedman H, et al. (1994) MR imaging of high-grade cerebral gliomas: value of diffusion-weighted echoplanar pulse sequences. Am J Roentgenol 162:671–677
Cha S, Knopp EA, Johnson G, et al. (2002) Intracranial mass lesions: dynamic contrast-enhanced susceptibility-weighted echo-planar perfusion MR imaging. Radiology 223:11–29
Maia ACM, Malheiros SMF, da Rocha AJ, et al. (2005) MR cerebral blood volume maps correlated with vascular endothelial growth factor expression and tumor grade in nonenhancing gliomas. Am J Neuroradiol 26:777–783
Law M, Yang S, Babb JS, et al. (2004) Comparison of cerebral blood volume and vascular permeability from dynamic susceptibility contrast-enhanced perfusion MR imaging with glioma grade. Am J Neuroradiol 25:746–755
Lev MH, Ozsunar Y, Henson JW, et al. (2004) Glial tumor grading and outcome prediction using dynamic spin-echo MR susceptibility mapping compared with conventional contrast-enhanced MR: confounding effect of elevated rCBV of oligodendrogliomas. Am J Neuroradiol 25:214–221
Cha S, Tihan T, Crawford F, et al. (2005) Differentiation of low-grade oligodendrogliomas from low-grade astrocytomas by using quantitative blood-volume measurements derived from dynamic susceptibility contrast-enhanced MR imaging. Am J Neuroradiol 26:266–273
Frayne R, Goodyear BG, Dickhoff P, et al. (2003) Magnetic resonance imaging at 3.0 Tesla: challenges and advantages in clinical neurological imaging. Invest Radiol 38:385–402
Di Costanzo A, Trojsi F, Tosetti M, et al. (2003) High-field proton MRS of human brain. Eur J Radiol 48:146–153
Counsell CE, Grant R (1998) Incidence studies of primary and secondary intracranial tumours: a systematic review of their methodology and results. J Neurooncol 37:241–250
Prados M (2000) Neoplasms of the central nervous system. In: Bast R, Kufe D, Pollock R, Weichselbaum R, Holland J, Frei E (eds) Cancer medicine, 5th edn. BC Decker, Hamilton, Ontario, pp 1055–1082
Yuh WT, Nguyen HD, Tali ET, et al. (1994) Delineation of gliomas with various doses of MR contrast material. Am J Neuroradiol 15:983–989
Pirzkall A, McKnight TR, Graves EE, et al. (2001) MR-spectroscopy guided target delineation for high-grade gliomas. Int J Radiat Oncol Biol Phys 50:915–928
Kleihues P, Cavenee WK (eds) Pathology and genetics of tumours of the nervous system. IARC Press, Lyon, France
Fallentin E, Skriver E, Herning M, et al. (1997) Gliomatosis cerebri: an appropriate diagnosis? Case reports. Acta Radiol 38:381–390
Barnard RO, Geddes JF (1987) The incidence of multifocal cerebral gliomas: a histologic study of large hemisphere sections. Cancer 60:1519–1531
Artigas J, Cervos-Navarro J, Iglesias JR, et al. (1985) Gliomatosis cerebri: clinical and histological findings. Clin Neuropathol 4:135–148
Castillo M, Smith JK, Kwock L, Wilber K (2001) Apparent diffusion coefficients in the evaluation of high-grade cerebral gliomas. Am J Neuroradiol 22:60–64
Law M, Cha S, Knopp EA, et al. (2002) High-grade gliomas and solitary metastases: differentiation by using perfusion and proton spectroscopic MR imaging. Radiology 222:715–721
Tzika AA, Astrakas LG, Zarifi MK, et al. (2003) Multiparametric MR assessment of pediatric brain tumors. Neuroradiology 45:1–10
Chiang IC, Kuo Y-T, Lu C-Y, et al. (2004) Distinction between high-grade gliomas and solitary metastases using peritumoral 3-T magnetic resonance spectroscopy, diffusion, and perfusion imagings. Neuroradiology 46:619–627
Strugar JG, Criscuolo GR, Rothbart D, Harrington WN (1995) Vascular endothelial growth/permeability factor expression in human glioma specimens: correlation with vasogenic brain edema and tumor-associated cysts. J Neurosurg 83:682–689
Cha S, Johnson G, Wadghiri YZ, et al. (2003) Dynamic, contrast-enhanced perfusion MRI in mouse gliomas: correlation with histopathology. Magn Reson Med 49:848–855
Strugar J, Rothbart D, Harrington W, Criscuolo GR (1994) Vascular permeability factor in brain metastases: correlation with vasogenic brain edema and tumor angiogenesis. J Neurosurg 81:560–566
Eis M, Els T, Hoehn-Berlage M (1995) High resolution quantitative relaxation and diffusion MRI of three different experimental brain tumors in rat. Magn Reson Med 34:835–844
Black PM (1993) Meningiomas. Neurosurgery 32:643–657
Mahmood A, Caccamo DV, Tomecek FJ, et al. (1993) Atypical and malignant meningiomas: a clinicopathological review. Neurosurgery 33:955–963
Maier H, Ofner D, Hittmair A, et al. (1992) Classic, atypical, and anaplastic meningioma: three histopathological subtypes of clinical relevance. J Neurosurg 77:616–623
Nakano T, Asano K, Miura H, et al. (2002) Meningiomas with brain edema. Radiological characteristics on MRI and review of the literature. Clin Imaging 26: 243–249
Yang S, Law M, Zagzag D, et al. (2003) Dynamic contrast-enhanced perfusion MR imaging measurements of endothelial permeability: differentiation between atypical and typical meningiomas. Am J Neuroradiol 24:1554–1559
Cho Y-D, Choi G-H, Lee S-P, Kim J-K (2003) 1H-MRS metabolic patterns for distinguishing between meningiomas and other brain tumors. Magn Reson Imaging 21:663–672
Provenzale JM, McGraw P, Mhatre P, et al. (2004) Peritumoral brain regions in gliomas and meningiomas: investigation with isotropic diffusion-weighted MR imaging and diffusion-tensor MR imaging. Radiology 232:451–460
Cha S (2004) Perfusion MR imaging of brain tumors. Top Magn Reson Imaging 15:279–289
Jellinger KA, Paulus W (1992) Primary central nervous system lymphomas — an update. J Cancer Res Clin Oncol 119:7–27
Lai R, Rosenblum MK, DeAngelis LM (2002) Primary CNS lymphoma. A whole-brain disease? Neurology 59:1557–1562
Larocca LM, Capello D, Rinelli A, et al. (1998) The molecular and phenotypic profile of primary central nervous system lymphoma identifies distinct categories of the disease and is consistent with histogenetic derivation from germinal center-related B cells. Blood 92:1011–1019
Buhring U, Herrlinger U, Krings T, et al. (2001) MRI features of primary central nervous system lymphomas at presentation. Neurology 57:393–396
Küker W, Nägele T, Korfel A, et al. (2005) Primary central nervous system lymphomas (PCNSL): MRI features at presentation in 100 patients. J Neurooncol 72:169–177
Hartmann M, Heiland S, Harting I, et al. (2003) Distinguishing of primary cerebral lymphoma from high-grade glioma with perfusion-weighted magnetic resonance imaging. Neurosci Lett 338:119–122
Onda K, Wakabayashi K, Tanaka R, Takahashi H (1999) Intracranial malignant lymphomas: clinicopathological study of 26 autopsy cases. Brain Tumor Pathol 16:29–35
Deangelis LM (2001) Brain tumors. N Engl J Med 344:114–123
Jeyapalan S, Batchelor T (2000) Diagnostic evaluation of neurologic metastases. Cancer Invest 18:381–394
Hwang T, Close T, Grego J, et al. (1996) Predilection of brain metastasis in grey and white matter junction and vascular border zones. Cancer 77:1551–1555
Krabbe K, Gideon P, Wagn P, et al. (1997) MR diffusion imaging of human intracranial tumours. Neuroradiology 39:483–489
Kremer S, Grand S, Berger F (2003) Dynamic contrast-enhanced MRI: differentiating melanoma and renal carcinoma metastases from high-grade astrocytomas and other metastases. Neuroradiology 45:44–49
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Di Costanzo, A. et al. (2006). 3.0 T Imaging of Brain Tumours. In: Salvolini, U., Scarabino, T. (eds) High Field Brain MRI. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-31776-7_18
Download citation
DOI: https://doi.org/10.1007/3-540-31776-7_18
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-31775-3
Online ISBN: 978-3-540-31776-0
eBook Packages: MedicineMedicine (R0)